Gammaproteobacteria
Gammaproteobacteria is a class of several medically, ecologically, and scientifically important groups of bacteria. An exceeding number of species of this class are pathogenic. The class includes a variety of important pathogens, such as Escherichia, Salmonella, Yersinia, Legionellales, and others.
Taxonomy[edit]
The Gammaproteobacteria class is a part of the Proteobacteria phylum, which is one of the largest phyla and contains a vast diversity of bacterial species. The Gammaproteobacteria class is further divided into several orders, including Enterobacterales, Vibrionales, Pseudomonadales, and others.
Characteristics[edit]
Gammaproteobacteria are Gram-negative bacteria, which means they do not retain the violet crystal violet stain used in the Gram staining method of bacterial differentiation. They are usually rod-shaped and are found in a variety of environments, including water, soil, and humans.
Pathogenicity[edit]
Many species of Gammaproteobacteria are pathogenic and can cause diseases in humans and animals. For example, Escherichia coli is a common cause of food poisoning, while Salmonella species can cause salmonellosis and typhoid fever. Yersinia pestis, the causative agent of plague, is also a member of this class.
Ecological Importance[edit]
In addition to their role as pathogens, Gammaproteobacteria also play important roles in various ecological processes. For example, they are involved in the nitrogen cycle, where they convert nitrogen gas into a form that can be used by plants. Some species are also involved in the sulfur cycle.
See Also[edit]
References[edit]
-
Vibrio cholerae
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
